Latest revenue
$810.9M
as of 2026-03-31
Latest net income
$-35.9M
as of 2026-03-31
Net margin
-4.4%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $1.75B
- Enterprise value
- $1.75B
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $24.10
- 52-wk low
- $11.41
- Beta
- —
- Shares out
- 130.8M
5-year trend
What this company does
Item 1. Business Overview Surgery Partners, Inc., a Delaware corporation, acting through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. Unless the context otherwise indicates, Surgery Partners, Inc. and its subsidiaries are referred to herein as "Surgery Partners," "we," "us," "our" or the "Company." We are a leading healthcare services company with an integrated outpatient delivery model focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. We are one of the largest and fastest growing surgical services businesses in the United States ("U.S."),…
AI summary unavailable — showing raw filing excerpt
Generated from SGRY's filing dated 2026-03-02
Key risks
Table of Contents Item 1A. Risk Factors Risk Factors Summary Below is a summary of the principal factors that make an investment in our common stock speculative or risky. This summary does not address all of the risks that we face. A discussion of the risks we face can be found below under the heading "Risk Factors" and should be carefully considered, together with other information in this Annual Report and our other filings with the SEC, before making an investment decision regarding our common stock. Business and Operational Risks •We depend on payments from third-party payors, including government health care programs and private insurance organizations. If these payments are reduced or…
AI summary unavailable — showing raw filing excerpt
Generated from SGRY's filing dated 2026-03-02
Profitability
Operating margin
11.8%
5.1%Net margin
-2.4%
56.4%Return on equity
-4.5%
51.6%Return on assets
-1.0%
55.0%Leverage
Debt / equity
3.74×
9.7%Long-term debt / equity
2.10×
15.2%Debt / assets
78.9%
2.1%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $810.9M | +4.5% | $-35.9M | +4.8% | -4.4% |
Q4 2025 2025-12-31 | $885.0M | +2.4% | $-15.0M | +86.2% | -1.7% |
Q3 2025 2025-09-30 | $821.5M | +6.6% | $-22.7M | +28.4% | -2.8% |
Q2 2025 2025-06-30 | $826.2M | +8.4% | $-2.5M | +83.9% | -0.3% |
Q1 2025 2025-03-31 | $776.0M | +8.2% | $-37.7M | -204.0% | -4.9% |
Q4 2024 2024-12-31 | $864.4M | — | $-108.5M | — | -12.6% |
Q3 2024 2024-09-30 | $770.4M | +14.3% | $-31.7M | -546.9% | -4.1% |
Q2 2024 2024-06-30 | $762.1M | +14.2% | $-15.5M | -158.3% | -2.0% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-General Medical & Surgical Hospitals, NEC · SIC 8062
Your notes
Keep private notes on SGRY — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$3.5M
Net activity
−$3.5M
Distinct insiders
9
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns SGRY
Institutional value
$477.9M
Total shares held
40.4M
Distinct holders
88
-92 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | UBS Group AG | 10.2M | $121.5M | +2.4M (+30.6%) | Added |
| 2 | BlackRock, Inc. | 5.7M | $67.5M | -30.2K (-0.5%) | Trimmed |
| 3 | DIMENSIONAL FUND ADVISORS LP | 5.3M | $63.1M | +389.8K (+7.9%) | Added |
| 4 | Clearbridge Investments, LLC | 4.1M | $49.1M | -110.4K (-2.6%) | Trimmed |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.6M | $43.3M | — | New |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 3.4M | $40.9M | — | New |
| 7 | HSBC HOLDINGS PLC | 1.9M | $22.6M | -1.9M (-50.4%) | Trimmed |
| 8 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.6M | $18.9M | +488.8K (+44.4%) | Added |
| 9 | Hudson Bay Capital Management LP | 607.8K | $7.2M | +2.3K (+0.4%) | Added |
| 10 | VANGUARD FIDUCIARY TRUST CO | 489.6K | $5.8M | — | New |
| 11 | JPMORGAN CHASE & CO | 336.4K | $3.9M | +191.0K (+131.3%) | Added |
| 12 | Bank of New York Mellon Corp | 301.0K | $3.6M | -7.5K (-2.4%) | Trimmed |
| 13 | BNP PARIBAS FINANCIAL MARKETS | 281.4K | $3.4M | +165.0K (+141.8%) | Added |
| 14 | Invesco Ltd. | 208.9K | $2.5M | +25.6K (+13.9%) | Added |
| 15 | Nuveen, LLC | 166.8K | $2.0M | +1.1K (+0.6%) | Added |
| 16 | KENNEDY CAPITAL MANAGEMENT LLC | 156.6K | $1.9M | -59.1K (-27.4%) | Trimmed |
| 17 | Swiss National Bank | 153.5K | $1.8M | +1.7K (+1.1%) | Added |
| 18 | TD Waterhouse Canada Inc. | 138.9K | $1.7M | +23.5K (+20.4%) | Added |
| 19 | PRINCIPAL FINANCIAL GROUP INC | 140.6K | $1.7M | +19.1K (+15.7%) | Added |
| 20 | WESBANCO BANK INC | 120.0K | $1.4M | +0 (+0.0%) | No change |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once SGRY's latest filing finishes processing.